You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Eicosapentaenoic acid ethyl ester

Showing 1 - 25 of 8,176
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bipolar Disorder Trial in New York (Ethyl Eicosapentaenoic Acid)

Withdrawn
  • Bipolar Disorder
  • Ethyl Eicosapentaenoic Acid
  • New York, New York
    New York State Psychiatric Institute/Columbia University Medical
Oct 12, 2022

Type 2 Diabetes, Coronary Artery Disease Trial in Boston (Icosapent ethyl)

Terminated
Has Results
  • Type 2 Diabetes
  • Coronary Artery Disease
  • Icosapent ethyl
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 22, 2022

Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver

Recruiting
  • Colon Cancer Liver Metastasis
  • Icosapent Ethyl Oral Capsule
  • Placebo
  • Leeds, United Kingdom
  • +1 more
Sep 27, 2021

Liver Metastasis, Colon Cancer Trial in United Kingdom (Icosapent Ethyl, Placebo)

Recruiting
  • Liver Metastasis
  • Colon Cancer
  • Icosapent Ethyl
  • Placebo
  • Oxford, Oxfordshire, United Kingdom
  • +12 more
Nov 7, 2022

Alzheimer's Disease Trial in Madison (icosapent ethyl (IPE), gel cap )

Active, not recruiting
  • Alzheimer's Disease
  • icosapent ethyl (IPE)
  • gel cap placebo
  • Madison, Wisconsin
    William S. Middleton Memorial Veterans Hospital, Madison, WI
Jul 23, 2021

Epilepsy Trial in Palo Alto (Vinpocetine)

Suspended
  • Epilepsy
  • Palo Alto, California
    Stanford University
Jul 7, 2022

Healthy Adults Trial in Rimouski (MAG-EPA/MAG-DHA, TG-EPA/TG-DHA, EE-EPA/EE-DHA)

Completed
  • Healthy Adults
  • MAG-EPA/MAG-DHA
  • +2 more
  • Rimouski, Quebec, Canada
    SCF pharma
Apr 28, 2021

Diabetes, Non-Insulin-Dependent, Hypertriglyceridemia Trial in Baton Rouge (Metformin Eicosapentaenoate, Metformin HCl and

Completed
  • Diabetes Mellitus, Non-Insulin-Dependent
  • Hypertriglyceridemia
  • Metformin Eicosapentaenoate
  • Metformin HCl and Vascepa
  • Baton Rouge, Louisiana
    Pennington Biomedical Research Center
Apr 25, 2022

Hypertriglyceridemia Trial in Changsha (Placebo, Ethyl Icosapentate)

Recruiting
  • Hypertriglyceridemia
  • Placebo
  • Ethyl Icosapentate
  • Changsha, China
    Mochida Investigational sites
Jun 9, 2022

Hypertriglyceridemia Trial (Omega-3-acid ethyl ester or Placebo)

Completed
  • Hypertriglyceridemia
  • Omega-3-acid ethyl ester or Placebo
  • (no location specified)
Mar 3, 2021

Diabetes Type 2, Hypertriglyceridemia, Diabetes Trial in Ioannina (EPAVasc, Corn Oil)

Not yet recruiting
  • Diabetes Type 2
  • +2 more
  • EPAVasc
  • Corn Oil
  • Ioannina, Epirus, Greece
    Atherothrombosis Research Centre / Laboratory of Biochemistry, U
Nov 13, 2023

Cardiovascular Diseases, Cardiovascular Risk Factor, Triglycerides High Trial in Canada (Icosapent Ethyl 1000 MG Oral Capsule

Recruiting
  • Cardiovascular Diseases
  • +3 more
  • Icosapent Ethyl 1000 MG Oral Capsule [Vascepa]
  • North York, Ontario, Canada
  • +3 more
Nov 7, 2022

COVID-19, Inflammatory Response Trial in Toronto (Icosapent ethyl)

Completed
  • COVID-19
  • Inflammatory Response
  • Icosapent ethyl
  • Toronto, Ontario, Canada
    North York Diagnostic and Cardiology Clinic
Dec 21, 2021

Colorectal Adenoma, Colorectal Cancer, Endoscopic Surgery Trial in Boston (AMR101)

Completed
  • Colorectal Adenoma
  • +4 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 18, 2022

Lipid Disorder, Triglycerides High, Dyslipidemias Trial in Philadelphia (Icosapent Ethyl 1000 MG [Vascepa])

Completed
Has Results
  • Lipid Disorder
  • +2 more
  • Icosapent Ethyl 1000 MG [Vascepa]
  • Philadelphia, Pennsylvania
    Perelman School of Medicine at the University of Pennsylvania
Oct 15, 2021

Covid19, Atherosclerosis, Cardiovascular Diseases Trial in Oakland (Icosapent ethyl)

Active, not recruiting
  • Covid19
  • +3 more
  • Icosapent ethyl
  • Oakland, California
    Kaiser Permanente Northern California
Jan 7, 2022

COVID19 Trial in Rosario (Icosapent ethyl (IPE), Placebo)

Completed
  • COVID19
  • Icosapent ethyl (IPE)
  • Placebo
  • Rosario, Santa Fe, Argentina
    Instituto de Investigaciones Clínicas - Rosario
Sep 10, 2021

Optimal Gastrointestinal Absorption of Omega-3 Trial in Brisbane (Product 1 - AquaCelle Fish Oil Triglyceride, Product 2 -

Not yet recruiting
  • Optimal Gastrointestinal Absorption of Omega-3
  • Product 1 - AquaCelle Fish Oil Triglyceride
  • +2 more
  • Brisbane, Queensland, Australia
    RDC Global Pty Ltd
Aug 8, 2022

Cardiovascular Diseases Trial in Worldwide (AMR101, Placebo, Statin therapy)

Completed
Has Results
  • Cardiovascular Diseases
  • Birmingham, Alabama
  • +409 more
Mar 21, 2022

Malaria Trial in Beira (IR3535 (3-(N-acetyl-N-butyl) aminopropionic acid ethyl ester) house spraying)

Recruiting
  • Malaria
  • IR3535 (3-(N-acetyl-N-butyl) aminopropionic acid ethyl ester) house spraying
  • Beira, Sofala, Mozambique
    Centro de Investigação Operacional da Beira, Instituto Nacional
May 20, 2021

Colon Cancer Trial in Boston (AMR101 (VASCEPA, icosapent ethyl))

Withdrawn
  • Colon Cancer
  • AMR101 (VASCEPA, icosapent ethyl)
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 10, 2021

Hypertriglyceridemia Trial in United States (Omega 3 pentaenoic acid, icosapent ethyl)

Completed
Has Results
  • Hypertriglyceridemia
  • Omega 3 pentaenoic acid
  • icosapent ethyl
  • Jacksonville, Florida
  • +7 more
Mar 3, 2022

Healthy Trial in Sherbrooke (Omega-3 + vitamin K2 (monoacylglycerol form), Omega-3 + vitamin K2 (ethyl ester))

Completed
  • Healthy
  • Omega-3 + vitamin K2 (monoacylglycerol form)
  • Omega-3 + vitamin K2 (ethyl ester)
  • Sherbrooke, Quebec, Canada
    Centre de Recherche sur le Vieillissement
May 8, 2020

Heart Failure Trial in Úbeda (Polyunsaturated fatty acids omega-3, Placebo)

Completed
  • Heart Failure
  • Polyunsaturated fatty acids omega-3
  • Placebo
  • Úbeda, Jaen, Spain
    Hospital San Juan de la Cruz
Feb 9, 2021

Hypertriglyceridemia Trial in Torrance, Murray (Vascepa, )

Completed
Has Results
  • Hypertriglyceridemia
  • Torrance, California
  • +1 more
Oct 4, 2021